Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Accounts Payables (2016 - 2025)

CV Sciences' Accounts Payables history spans 14 years, with the latest figure at $1.2 million for Q3 2025.

  • For Q3 2025, Accounts Payables fell 35.63% year-over-year to $1.2 million; the TTM value through Sep 2025 reached $1.2 million, down 35.63%, while the annual FY2024 figure was $1.9 million, 16.63% down from the prior year.
  • Accounts Payables for Q3 2025 was $1.2 million at CV Sciences, down from $1.4 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $2.7 million in Q1 2022 and bottomed at $646000.0 in Q2 2021.
  • The 5-year median for Accounts Payables is $2.2 million (2022), against an average of $2.0 million.
  • The largest annual shift saw Accounts Payables soared 282.82% in 2022 before it plummeted 39.19% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $2.6 million in 2021, then fell by 12.96% to $2.3 million in 2022, then grew by 1.09% to $2.3 million in 2023, then decreased by 16.63% to $1.9 million in 2024, then tumbled by 36.94% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Accounts Payables are $1.2 million (Q3 2025), $1.4 million (Q2 2025), and $1.5 million (Q1 2025).